To measure actin/myosin protein breakdown, the 24 h excretion of N τ -methylhistidine (3MH) is used. However, in mice, this method is invalid. Therefore we have developed a liquid chromatography-MS technique to measure the tracer/tracee ratio and concentration of 3MH in plasma, enabling an in vivo primed constant infusion protocol with a deuterated stable isotope of 3MH. We tested this model by giving a primed constant infusion of
INTRODUCTION
A method used commonly to determine myofibrillar protein breakdown (MPB) is based on the presence of the methylated histidine N τ -methylhistidine (3MH) in actin and myosin heavy-chain proteins [1] . These proteins can be found mainly in muscle and, to a lesser degree, in other tissues such as intestine and skin. When actin/myosin proteins are broken down, 3MH is released. Because 3MH has no specific tRNA, it cannot be re-used for protein synthesis and its only fate is excretion in urine. Therefore the amount of 3MH found in urine can be used to determine the amount of actin/myosin proteins broken down in the body [2] . This method requires quantitative collection of urine, which is usually done for 24 h, and is based on the assumption that all of the released 3MH ends up directly in urine, without being metabolized or pooled before excretion [3] .
The development of transgenic and knockout mice has created possibilities to obtain new information on metabolic processes. The ability to measure whole-body (Wb) MPB in these genetically-modified mice could produce new insights into protein metabolism. However, the urine excretion method is invalid in mice because, as in pigs [4] , sheep [5] and rats [1] , a large part of 3MH is not excreted directly into urine [5] . As a result, excretion in urine underestimates the true production rate of 3MH. 3MH is retained and temporarily stored in a sink of 3MH, possibly in muscle, rather than excreted into urine [6, 7] . Moreover, 3MH is extensively metabolized via various pathways: a portion enters a histamine pathway to end up as N τ -methylimidazolacetic acid [6] , a portion is acetylated to N τ -acetyl-methylhistidine [6, 7] , and another portion is metabolized via unknown pathways [6] . Both Murray et al. [6] and Harris et al. [7] have studied urinary recovery of radioactively labelled 3MH in mice. They found that in male mice, only 70 % of the radioactive label was excreted into urine after 24 h and, of this 70 %, only 70 % was actually excreted as 3MH without being metabolized. Thus merely 50 % of the released 3MH is recovered in the urine of male mice. In female mice, 90 % of the radioactive label was excreted after 24 h and, of this 90 %, only 30 % was excreted as 3MH without being metabolized. Thus, merely 30 % of the released 3MH is recovered in the urine of female mice. In conclusion, 3MH excretion in urine is underestimated both in male and female mice and, as a consequence, cannot be used to determine MPB.
We wanted to develop a method determining the Wb production rate of 3MH that avoids the problems posed by metabolism and delayed excretion of 3MH in the urine of mice. This method will not give an answer to the origin of 3MH in the body, but a primed constant tracerinfusion protocol [8] would enable Wb measurements of 3MH production in mice. Besides, such a method has several additional advantages. It enables the measurement of acute changes in actin/myosin protein breakdown, in contrast with the 24 h urine excretion method. Furthermore, by simultaneous infusion of other stable isotope tracers, it is possible to measure different aspects of protein and amino acid metabolism from a single blood sample.
To test a primed constant infusion protocol with the stable isotope l- [3- [9] and protein synthesis [10] . Since there is, at present, no other method to measure actin/myosin protein breakdown in mice, it is not possible to validate this method by comparing it with a known method. Neither is it possible to extend the data achieved with our stable isotope study to a 24 h period and correct them for the expected underestimation with the data of Murray et al. [6] and Harris et al. [7] , since our measurements will yield information on the production of 3MH at the specific moment of blood sampling. As MPB is expected to fluctuate during a 24 h time course, one measurement at a certain time point cannot be converted into the 3MH production rate of the whole period. To study an extended time course, it is necessary to obtain multiple blood samples in time, which is a problem because of the limited blood volume of mice.
METHODS

Animals
Male Swiss mice (20-30 g ) were obtained from the breeding facilities at the Centralized Animals Facility at Maastricht University (Maastricht, The Netherlands). Mice were fed standard laboratory chow (Hope Farms, Woerden, The Netherlands) and were subject to standard 12 h light/dark cycle periods (7:30 a.m. to 7:30 p.m.). Room temperature was maintained at 25
• C. Water was provided ad libitum throughout the experiment. Experiments were performed in accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals [11] , and approved by the Ethical Committee of Animal Research of Maastricht University.
Experimental protocol
All experiments started between 6:00 and 8:00 a.m. At t = −2 h, animals were weighed and food was withheld, but drinking water was provided ad libitum. Intake of nutrients was, therefore, equal in all groups. At t = 0 h, mice received lipopolysaccharide (LPS, 250 µg in 0.5 ml of saline; Escherichia coli O55:B5; Sigma, St. Louis, MO, U.S.A.) intraperitoneally (i.p.) [12] . Control animals received a corresponding volume of saline. The tracerinfusion protocol was conducted in three experimental groups: mice receiving saline i.p. (CON; n = 9), mice receiving saline i.p. and starved for 9 h (STA; n = 10), and mice receiving LPS i.p. and starved for 9 h (STA + LPS; n = 10).
Tracer-infusion protocol
At t = 0 h (CON group) or t = 9 h (STA and STA + LPS groups), the animals were weighed again to determine weight loss compared with t = −2 h, and anaesthesia was induced by injection of a mixture of ketamine (62.5 mg/kg of body weight; Nimatek, AUV, Cuyk, The Netherlands) and medetomidine (400 µg/kg of body weight; Domitor, Farmos, Espoo, Finland) i.p. [13] . Anaesthesia was maintained with a continuous subcutaneous infusion of a mixture of ketamine (17.5 mg · kg of body weight −1 · h −1 ) and medetomidine (112 µg · kg of body weight −1 · h −1 ) [13] . During the surgical procedures, the mice were kept at 37
• C using a temperature controller (Technical Service, Table 1 for concentrations and infusion rates). In a pilot experiment, the time to reach tracer steady-state in mice was determined (n = 6). Steady-state was present from 20-60 min (Figure 1 ; P > 0.05 with ANOVA for repeated measures). In the current experiment, we therefore sampled blood at 30 min after the start of the primed continuous infusion of stable isotopes.
Blood sampling and processing
Arterial blood (100 µl/animal) was collected from the carotid artery into heparinized cups (Sarstedt, Nümbrecht, Germany) on ice, and centrifuged (8500 g for 4 min at 4
• C) to obtain plasma. For the determination of amino acid concentrations and tracer/tracee ratios (TTRs), 65 µl of plasma was added to 4 mg of solid 5 -sulphosalicylic acid, vortexed, frozen in liquid nitrogen and stored at −80 • C.
Analysis of samples
Plasma amino acid concentrations and enrichments, calculated as TTRs, were measured using a fully automated liquid chromatography-MS system, using precolumn derivatization with o-phthaldialdehyde [14, 15] . Detailed information on the accuracy and precision of this method has been reported previously [15] . Nonenriched blood samples from mice were used to subtract background enrichment from the experiment samples.
Calculations
TTR is an equivalent of specific activity. Therefore formulae were derived from metabolic studies using radioactive tracers. 
Statistical analysis
Results are presented as means + − S.E.M. Significant differences between treatment groups were tested using one-way ANOVA with the least-significant difference used as the post-hoc test (SPSS for Windows Version 7.5; SPSS Inc., Chicago, IL, U.S.A.). Significance was twotailed defined as P < 0.05.
RESULTS
Starvation decreased body weight compared with control (1.4 + − 0.3 g in the STA group versus 0.7 + − 0.1 g in the CON group; P < 0.05), whereas starvation + LPS did not result in a further decrease (1.6 + − 0.1 g in the STA + LPS group). Arterial plasma concentrations (Table 2) of Phe and Tyr remained unchanged in the STA and STA+LPS groups. Starvation increased the arterial plasma concentration of 3MH with an additional increase after LPS.
Wb MPB, measured from Wb Ra of 3MH, was unchanged after starvation (P = 0.11) ( Table 3) . A trend (P = 0.06) towards an increase in Wb MPB from 0.48 + − 0.07 nmol · 10 g of body weight
in the STA group to 0.82 + − 0.14 nmol · 10 g of body weight −1 · min −1 in the STA + LPS group was observed.
Wb TPB, measured from Wb Ra of Phe, was not significantly different between the groups (Table 3) . Furthermore, Wb protein synthesis and NPB were not significantly different between the groups (Table 3) . The contribution of MPB to TPB was significantly lower in the STA group than the CON group (30 + − 4 % and 54 + − 14 % respectively; P < 0.05), and was significantly higher in the STA + LPS group than STA group (52 + − 7 % and 30 + − 4 % respectively; P < 0.05).
DISCUSSION
Aim
The present study was undertaken to test a primed constant tracer-infusion protocol with a deuterated stable isotope of 3MH to measure actin/myosin protein breakdown in mice. We were able to assess Wb production rates of 3MH in mice, which, up to now, has been impossible, because of the invalid interpretation of 3MH urinary excretion in mice. Urinary excretion of 3MH is known to underestimate MPB by approx. 50 % in male and 70 % in female mice and, as a consequence, cannot be used to determine MPB. This problem was overcome using a stable isotope protocol. Even if 3MH was metabolized in the tissue where it is produced, the 3MH production measured with a tracer technique will produce a true value, assuming the tracer enrichment of the plasma pool to be representative for the enrichment of the tissue pool. Also, such a protocol enables measurements of acute changes without the need of a bolus protocol with multiple blood samples [18] . Because of the limited blood volume in mice, this is an important advantage of the method presented in the current study.
Arterial concentrations
There was no correlation between arterial plasma concentrations of 3MH and Wb MPB measured with [ 2 H 3 ]3MH. This illustrates that arterial plasma concentrations of 3MH are not representative of Wb actin/myosin protein breakdown.
Design
When comparing the priming dose and infusion rate of the different stable isotope tracers used, it is remarkable that the infusion rate of [ 2 H 3 ]3MH is relatively small compared with the amount of primer that is used. We calculated the infusion rate from pilot experiments by fitting curves of Ra of 3MH obtained with this tracer in mice. The priming dose was calculated from a measured concentration of 8 µM 3MH in plasma of mice in the pilot. Assuming that the tracer is distributed across the water pool, which has a volume of 70 % of body weight, the priming dose was estimated to be 29 nmol/mouse. Because steady-state was reached after 20 min (Figure 1) , apparently no other large pools of 3MH exist in mice that contribute to 3MH turnover. This is in contrast with 
MPB versus TPB
Compared with the control group, there were no significant effects of starvation on TPB, MPB, protein synthesis and NPB. However, the contribution of MPB to TPB was decreased. Evidently, myofibrillar proteins are initially spared during starvation. This fits with the observation that loss of muscle protein is initially prevented and only becomes prominent after longer food deprivation, whereas the liver and other viscera lose considerable protein during the first phase of starvation [19, 20] . It is probably related to different phases of protein breakdown after various levels of metabolic stress. We hypothesized that the contribution of MPB to TPB would increase when starvation was accompanied by endotoxin administration compared with starvation alone. Indeed, by adding LPS as an extra stressor to starvation, the contribution of MPB to TPB increased. In addition, the data on MPB and TPB illustrate that measuring both provides different information on protein breakdown and is thus valuable. Starvation studies in rats have also reported different results for MPB and TPB [21, 22] . Distinctive regulation pathways for myofibrillar and non-myofibrillar proteins might contribute to the different responses. In starvation, for example, protein breakdown in non-muscle tissues has contributed to a lysosomal activity process [23] [24] [25] , whereas the ATP-ubiquitin-dependent proteolytic pathway has been held responsible for protein breakdown in skeletal muscle [25] [26] [27] and myofibrillar proteins [28] . In endotoxaemia, a similar pattern might be present, since the ATP-ubiquitin-dependent proteolytic pathway was responsible for protein breakdown of skeletal muscle in sepsis as well [29] [30] [31] [32] .
These in vivo data show no changes in Wb TPB after LPS or starvation and we have shown this previously in LPS-treated mice [33] . Others have measured TPB after starvation in vitro or ex vivo in rats and reported an increase [28, 34, 35] , a decrease [21, 35] or no change [22, 36] in TPB in muscle perfusions or incubations. Results appeared to be influenced by the age of the animals and the duration of starvation [28, 35] . More in vivo studies will be necessary to confirm information obtained from these in vitro and ex vivo results.
Wb versus organ level
The present in vivo data give information on 3MH production at the Wb level. In this experiment, we have not assessed the 3MH production rates of different organs, since this requires measurements across organs. Using the current primed constant stable isotopeinfusion protocol in combination with measurements across organs could identify different sources of 3MH in the body. Such data could answer the question as to what extent different organs contribute to total 3MH production. Other than skeletal muscle, intestine, skin, lungs and the vascular system contain actin/myosin proteins as well. In addition to the amount of myofibrillar proteins, the turnover rate determines the amount of 3MH that is produced. Since intestine is thought, in particular, to have a high turnover rate, it might contribute significantly to Wb 3MH production [37] [38] [39] [40] [41] [42] .
Clinical application
The current stable isotope protocol to measure 3MH production rates can easily be transferred to a human model, thus creating the possibility to assess acute changes in MPB in humans, in contrast with 24 h urine collection, which measures changes over time. It would also enable simultaneous infusion of other stable isotope tracers to assess different aspects of protein and amino acid metabolism at the same time. The protocol presented in the current study will also exclude the necessity of quantitative urine collection. The latter is an important advantage, especially in the non-clinical setting, where continuous sampling of urine can be a problem. Neither is it necessary to adjust the subjects' diet before and during the study period in order to prevent contamination of urine with 1-methylhistidine, which is present in meat.
Conclusion
In conclusion, we have shown that MPB in mice is measurable with this tracer method. Up to now, this was not possible, because urinary excretion of 3MH in mice is not representative of MPB. Therefore studies with this primed constant stable isotope-infusion protocol with [ 2 H 3 ]3MH can provide valuable information on protein metabolism in mice. The proposed protocol can be applied easily to human studies and will, therefore, provide measurements of acute changes in MPB and exclude the need for collecting quantitative urine samples in order to determine 3MH excretion in urine.
